IBD Ventures

Is your organization engaged in the discovery or development of a novel product with the potential to help patients with inflammatory bowel disease (IBD)? If so, we want to hear from you!

The Crohn's & Colitis Foundation seeks to accelerate the development of products that aim to improve the quality of life of patients with inflammatory bowel diseases. Toward that end, the Foundation has launched IBD Ventures, a new program and dedicated funding mechanism to support product-oriented research and development. Companies and academic investigators can apply. Funding up to $500,000 per project per year will be considered. In addition, funded programs will be offered accelerator resources and advising.

For eligibility, policies, and application instructions, click here. The first step is to submit a Letter of Intent. Applications may be submitted at any time. For more information, please refer to the program guidelines document.

Even if your organization is not interested in IBD Ventures at this time, we'd still like to hear from you—click here to subscribe to our email list, or send your questions to [email protected]

How to apply

Program information, LOI  and other application forms can be accessed and must be submitted through proposalCENTRAL.

  • Navigate to the "Grant Opportunities" tab (top right)
  • Filter by grant maker (select "Crohn's & Colitis Foundation") to find the application link for IBD Ventures

Upcoming Letter of Intent deadlines: February 5, 2021 and August 6, 2021

Questions? Read our FAQ, or contact us at [email protected]

Connect with us at a conference!

Event Date Location

Digestive Diseases Week

May 21-23, 2021


BIO Digital

June 10-18, 2021


Microbiome Movement – Drug Development Summit

June 29-July 1, 2021


Lyfebulb & Arena Pharmaceuticals: IBD challenge

September 9-10, 2021


IBD Innovate

November 18-19, 2021


Crohn's & Colitis Congress

January 20-22, 2022

Las Vegas